| Sep 18 |
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience
|
| Sep 17 |
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health
|
| Sep 17 |
Labcorp subsidiary prices $2B notes offering
|
| Sep 16 |
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034
|
| Sep 16 |
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
|
| Sep 12 |
Labcorp Stock Gains From Market Expansion Efforts Amid Macro Woes
|
| Sep 11 |
LH Stock Expected to Gain From the Ballad Health Acquisition Deal
|
| Sep 11 |
Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability
|
| Sep 6 |
Investors in Labcorp Holdings (NYSE:LH) have seen favorable returns of 59% over the past five years
|
| Sep 3 |
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
|
